Skip to main content

Table 5 In-hospital mortality in patients undergoing VA-ECMO for cardiogenic shock

From: In-hospital mortality and successful weaning from venoarterial extracorporeal membrane oxygenation: analysis of 5,263 patients using a national inpatient database in Japan

 

Patients, n

Deaths, n (%)

P value

Total

4658

3429

(73.6)

 

Age, years

   

<0.001

 19–39

271

170

(62.7)

 

 40–59

1079

738

(68.4)

 

 60–79

2741

2058

(75.1)

 

 ≥ 80

567

463

(81.7)

 

Sex

   

0.775

 Male

3399

2506

(73.7)

 

 Female

1259

923

(73.3)

 

Hospital volume per year

   

0.071

 0–9

1671

1263

(75.6)

 

 10–19

1554

1123

(72.3)

 

 ≥ 20

1433

1043

(72.8)

 

Body mass index, kg/m2

   

<0.001

 < 18.5

406

295

(72.7)

 

 18.5–24.9

2223

1521

(68.4)

 

 ≥ 25.0

1085

772

(71.2)

 

 Missing

944

841

(89.1)

 

Etiology

   

<0.001

 Ischemic heart disease

1968

1556

(79.1)

 

 Heart failure

1621

1099

(67.8)

 

 Valvular disease

640

493

(77.0)

 

 Myocarditis

186

106

(57.0)

 

 Cardiomyopathy

193

141

(73.1)

 

 Takotsubo cardiomyopathy

34

22

(64.7)

 

 Infectious endocarditis

16

12

(75.0)

 

Cardiac arrest

   

<0.001

 No

2471

1742

(70.5)

 

 Yes

2187

1687

(77.1)

 

Chronic renal failure

   

0.464

 No

4139

3040

(73.4)

 

 Yes

519

389

(75.0)

 

Liver failure

   

0.974

 No

4594

3382

(73.6)

 

 Yes

64

47

(73.4)

 

Central nervous system dysfunction

   

0.527

 No

4605

3392

(73.7)

 

 Yes

53

37

(69.8)

 

Duration of intubation prior to VA-ECMO, days

   

<0.001

 0

2576

2007

(77.9)

 

 1

33

23

(69.7)

 

 ≥ 2

115

66

(57.4)

 

 Missing

1934

1333

(68.9)

 

Use of intra-aortic balloon pumping

   

<0.001

 No

1828

1438

(78.7)

 

 Yes

2830

1991

(70.4)

 

Use of continuous renal replacement therapy

  

<0.001

 No

2893

2058

(71.1)

 

 Yes

1765

1371

(77.7)

 
  1. VA-ECMO venoarterial extracorporeal membrane oxygenation